Beranda › Karsinoma Urotelial (Sel Transisional)
Uji klinis Karsinoma Urotelial (Sel Transisional) yang merekrut di AS
72 studi untuk Karsinoma Urotelial (Sel Transisional) merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Nashville, TN23 studi
- New York City, NY22 studi
- Dallas, TX18 studi
- Edison, NJ18 studi
- Houston, TX18 studi
- Los Angeles, CA17 studi
- Queens, NY15 studi
- Chicago, IL14 studi
- Arlington, VA12 studi
- San Antonio, TX11 studi
- Boston, MA11 studi
- Austin, TX10 studi
- Orange, CA10 studi
- Philadelphia, PA9 studi
- Washington, DC9 studi
- Columbus, OH9 studi
- Baldwin Park, CA9 studi
- Atlanta, GA8 studi
- Cleveland, OH8 studi
- Jacksonville, FL8 studi
- Durham, NC8 studi
- Seattle, WA8 studi
- Irvine, CA8 studi
- Orlando, FL7 studi
- Omaha, NE7 studi
- Portland, OR7 studi
- San Francisco, CA7 studi
- St. Louis, MO7 studi
- New Rochelle, NY7 studi
- Staten Island, NY7 studi
- Greenburgh, NY7 studi
- Milwaukee, WI6 studi
- Denver, CO6 studi
- Phoenix, AZ6 studi
- New Haven, CT6 studi
- Detroit, MI6 studi
- Gainesville, FL6 studi
- Oklahoma City, OK6 studi
- Charlotte, NC6 studi
- Ann Arbor, MI6 studi
Berdasarkan negara bagian
- Alabama4 studi
- Arizona10 studi
- Arkansas5 studi
- California33 studi
- Colorado10 studi
- Connecticut7 studi
- Distrik Columbia7 studi
- Florida22 studi
- Georgia11 studi
- Idaho4 studi
- Illinois21 studi
- Indiana7 studi
- Iowa7 studi
- Kentucky4 studi
- Louisiana4 studi
- Maryland8 studi
- Massachusetts15 studi
- Michigan15 studi
- Minnesota7 studi
- Missouri10 studi
- Montana3 studi
- Nebraska7 studi
- Nevada3 studi
- New Jersey21 studi
- New York29 studi
- North Carolina15 studi
- Ohio17 studi
- Oklahoma8 studi
- Oregon8 studi
- Pennsylvania15 studi
- South Carolina8 studi
- South Dakota3 studi
- Tennessee25 studi
- Texas38 studi
- Utah6 studi
- Virginia21 studi
- Washington12 studi
- Wisconsin9 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06270706Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06265285Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05176483A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06524544A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07090499Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
Menerima peserta
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06262516The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05874921DBC-664 in Adult Patients With Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07705035A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05562830Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07421700A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07277413Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06047379A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07218380Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06439836Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT05239624Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07043972A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07532902GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT04977453A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07815665A Study of GEN1106 in Participants With Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07416123A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06040762Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06293898Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.